Global Glaucoma Therapeutics Market 2015-2019 - Market Trends, Size, Analysis & Forecast

1
Global Glaucoma Therapeutics Market 2014-2018
Market , Share, Size, Trends, Analysis, Demand
Forecast to 2019
2
Report Description
About Glaucoma Therapeutics Glaucoma is a disease
of the eye in which fluid pressure within the eye
increases. If left untreated the patient may lose
vision and even become blind. The exact etiology
of optic nerve damage due to glaucoma is not
fully known, but involves mechanical compression
and/or decreased blood flow in the optic nerve.
Based on whether the cause of the disease is
unknown or known, glaucoma is divided into two
types, open angle and closed angle glaucoma. Five
main classes of medical treatment are currently
used to lower intraocular pressure
prostaglandins, beta blockers, alpha adrenergic
agonists, carbonic anhydrase inhibitors, and
fixed dose combinations.   The Global Glaucoma
Therapeutics market will grow at a CAGR of 2.53
percent over the period 2013-2018. About Report
http//www.bigmarketresearch.com/global-glaucoma-t
herapeutics-2014-2018-market
3
Report Description
Covered in this Report The Global Glaucoma
Therapeutics market can be divided into five
segments Prostaglandins, Beta Blockers, Alpha
Adrenergic Agonists, Carbonic Anhydrase
Inhibitors, and Fixed Dose Combinations. To
calculate the market size, the report considers
the revenue generated from the sales of various
ophthalmic solutions used in the treatment of
glaucoma.   Global Glaucoma Therapeutics Market
2014-2018, has been prepared based on an in-depth
market analysis with inputs from industry
experts. The report covers the Americas and the
EMEA and APAC regions it also covers the Global
Glaucoma Therapeutics market landscape and its
growth prospects in the coming years. The report
also includes a discussion of the key vendors
operating in this market.   Key Regions
Americas EMEA APAC  
4
Key Regions
Key Vendors Allergan Inc. Merck Co. Inc.
Novartis AG Pfizer Inc.   Other Prominent
Vendors Acadia Pharmaceuticals Inc. AC
Immune SA Acorn Biomedical Inc. Advanced
Cell Technology Inc. Aerie Pharmaceuticals
Inc. Carl Zeiss Meditec Inc. Falcon
Pharmaceuticals Ltd. Inotek Pharmaceuticals
Corp. Lexicon Pharmaceuticals Inc. Neurotech
Pharmaceuticals Inc.  
5
Key Regions
Key Market Driver Increasing Prevalence of Eye
Disorders. For a full, detailed list, view our
report.   Key Market Challenge Increasing
Number of Patent Expirations. For a full,
detailed list, view our report.   Key Market
Trend Increase in Awareness of Glaucoma. For
a full, detailed list, view our report.
6
Key Regions
Key Questions Answered in this Report What will
the market size be in 2018 and what will the
growth rate be? What are the key market
trends? What is driving this market? What are
the challenges to market growth? Who are the
key vendors in this market space? What are the
market opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors? http//www.bigmarketresearch.
com/report-enquiry/17842
7
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/global-glaucoma-t
herapeutics-2014-2018-market
Stay With Us
TELEPHONE [phone] EMAIL
help_at_bigmarketresearch.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States